Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/296952
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Pleiotropic biological effects of Lupinus spp. protein hydrolysates

AutorCruz-Chamorro, Iván CSIC ORCID; Santos-Sánchez, Guillermo CSIC ORCID; Álvarez-López, Ana Isabel CSIC ORCID; Pedroche, Justo CSIC ORCID ; Lardone, Patricia Judith CSIC ORCID; Arnoldi, Anna; Lammi, Carmen; Carrillo-Vico, Antonio CSIC ORCID
Palabras claveBioactive compounds
Hydrolysates
Interleukin
LDL-R
Nutraceuticals
Oxidative stress
Fecha de publicación1-mar-2023
EditorElsevier
CitaciónTrends in Food Science and Technology 133: 244-266 (2023)
ResumenBackground: Over the last two decades, the demand for meat-free food has increased for health, environmental, and animal welfare reasons. Thus, research on the value of vegetable compounds as beneficial agents for human health has gained much attention. In particular, great interest has been shown in protein hydrolysation since this food technology facilitates the release of encrypted peptides with biological activities. In this sense, during the last 10 years, the biological activities of Lupinus spp. protein hydrolysates (LPHs) have been extensively studied. Scope and approach: The aim of this review is to address all studies (in silico, in vitro, and in vivo) in which the biological activities (antioxidant, anti-inflammatory, etc.) of LPHs were described, both the whole hydrolysate and the derived peptides. Moreover, the physicochemical characteristics of LPH peptides are evaluated, and challenges and future perspectives for their fast application have been discussed. Key findings and conclusions: LPHs exert many important biological effects in both the in vitro and in vivo systems. The main activities of LPHs described are antioxidant, immunomodulatory, hypotensive, hypoglycemic, and hypolipidemic. These findings point to LPHs as a possible new nutraceutical for human health, capable of preventing or treating some chronic diseases such as diabetes, dyslipidemia, and atherosclerosis. Finally, the development of a new generation of nanonutraceuticals to improve the metabolic stability and bioactivity of LPHs has been discussed.
Descripción23 Páginas.-- 4 Figuras.-- 4 Tablas
Versión del editorhttps://doi.org/10.1016/j.tifs.2023.02.011
URIhttp://hdl.handle.net/10261/296952
DOI10.1016/j.tifs.2023.02.011
ISSN0924-2244
Aparece en las colecciones: (IG) Artículos
(IBIS) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
TFST_2023_V133_P244.pdfArtículo principal6,12 MBAdobe PDFVista previa
Visualizar/Abrir
TFST_2023_V133_P244_MatSup.pdfMaterial suplementario581,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

5
checked on 23-abr-2024

WEB OF SCIENCETM
Citations

3
checked on 26-feb-2024

Page view(s)

46
checked on 28-abr-2024

Download(s)

29
checked on 28-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Este item está licenciado bajo una Licencia Creative Commons Creative Commons